Business Segments GlaxoSmithKline Pharmaceuticals Limited
Stocks
500660
INE159A01016
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,120.70 INR | +0.86% |
|
-2.11% | -14.17% |
Sales 2026 by Business Segment
Sales 2026 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 32.78B | 32.52B | 34.54B | 37.49B | 38.22B | |||||
Total Assets | 46.33B | 33.27B | 35.57B | 41.08B | 43.24B | |||||
Interest Expense | -19.96M | -18.12M | -17.99M | -13.14M | -27.32M | |||||
Income Tax Expense | 3.98B | 2.29B | 2.26B | 3.32B | 3.7B | |||||
CAPEX | -346M | -440M | -312M | -230M | -553M | |||||
EBT | 7.79B | 8.36B | 8.16B | 12.6B | 14.06B | |||||
D&A | 587M | 561M | 591M | 566M | 597M | |||||
Net Income | 16.95B | 6.11B | 5.9B | 9.28B | 10.36B |
Geographical Revenue Distribution History
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 31.96B | 31.88B | 33.92B | 36.99B | 37.7B | |||||
Total Assets | 6.11B | 6.17B | 6.01B | 5.46B | 5.7B | |||||
Foreign | 819M | 640M | 614M | 505M | 521M |
Select your edition
All financial news and data tailored to specific country editions
